(Q45101950)

9 December 2017

0 references

Questions unresolved by the third international study of infarct survival (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Cardiology and cardiovascular medicine

18 October 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

18 October 2022

author name string

B. E. Sobel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1632408

18 October 2022

D. Collen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1632408

18 October 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

full work available at URL

9 December 2017

https://api.elsevier.com/content/article/PII:0002914992906248?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

https://api.elsevier.com/content/article/PII:0002914992906248?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

American Journal of Cardiology

18 October 2022

published in

1 reference

9 December 2017

volume

70

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

385-389

1 reference

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

9 December 2017

cites work

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

18 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

18 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

18 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

18 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

18 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

18 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

18 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

18 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

18 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction

18 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

18 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

18 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

Announcement of protocol change in thrombolysis in myocardial infarction trial

18 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90624-8

18 October 2022

Identifiers

1 reference

9 December 2017

1 reference